júlí 2005
júlí 2005
júlí 2005
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
64 ELS tíðindi 7/05<br />
(21) 7909<br />
(22) 23.6.<strong>2005</strong><br />
(41) 23.6.<strong>2005</strong><br />
(51) C07D 401/12; C07D 471/04<br />
(54) Aðferð til að framleiða ljósfræðilega<br />
hrein virk efnasambönd.<br />
(71) Altana Pharma AG, Byk-Gulden-<br />
Str. 2, 78467 Konstanz, Þýskalandi.<br />
(72) Bernhard Kohl; Bernd Müller; Ralf<br />
Steffen Weingart; Konstanz,<br />
Þýskalandi.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 6.12.2002, EP, 02027273.8<br />
29.8.2003, DE, 103 40 255.1<br />
(85) 23.6.<strong>2005</strong><br />
(86) 3.12.2003, PCT/EP2003/013605<br />
(21) 7910<br />
(22) 23.6.<strong>2005</strong><br />
(41) 23.6.<strong>2005</strong><br />
(51) A61K 31/575; A61P 11/00; A61K<br />
9/00<br />
(54) Samsett lyf.<br />
(71) Altana Pharma AG, Byk-Gulden-<br />
Str. 2, 78467 Konstanz, Þýskalandi.<br />
(72) Klaus Dietzel, Konstanz; Degenhard<br />
Marx, Moos; Helgert Müller,<br />
Radolfzell; Christian Weimar,<br />
Konstanz; Þýskalandi.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 12.12.2002, EP, 02027797.6<br />
13.2.2003, DE, 103 06 213.0<br />
(85) 23.6.<strong>2005</strong><br />
(86) 11.12.2003, PCT/EP2003/014045<br />
(21) 7911<br />
(22) 23.6.<strong>2005</strong><br />
(41) 23.6.<strong>2005</strong><br />
(51) A61K 31/415; A61K 31/4164; C07D<br />
233/56; C07D 233/64; A61P 3/06;<br />
A61P 3/10<br />
(54) Ímídasólafleiður með sækni í alfa 2<br />
viðtakavirkni.<br />
(71) Orion Corporation, Orionintie 1, FI-<br />
02200 Espoo, Finnlandi.<br />
(72) Tomi Järvinen, Kuopio; Riku Niemi,<br />
Kajaani; Juhani Huuskonen,<br />
Jyväskylä; Finnlandi.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 5.12.2002, FI, 20022159<br />
(85) 23.6.<strong>2005</strong><br />
(86) 5.12.2003, PCT/FI2003/000933<br />
(21) 7912<br />
(22) 23.6.<strong>2005</strong><br />
(41) 23.6.<strong>2005</strong><br />
(51) A61K 31/202; A61K 31/557; A61P<br />
3/02<br />
(54) Notkun dókósahexensýru sem virks<br />
efnis til að meðhöndla fitukyrking.<br />
(71) Proyecto Empresarial Brudy, S.L.,<br />
C. Riera Sant Miquel 3, 2on 4a, E-<br />
08006 Barcelona, Spáni.<br />
(72) Juan Carlos Domingo Pedrol; Pere<br />
Domingo Pedrol; Barcelona, Spáni.<br />
(74) Sigurjónsson & Thor, ehf.,<br />
Skólavörðustíg 16, 101 Reykjavík.<br />
(30) 5.12.2002, ES, P-200202963<br />
(85) 23.6.<strong>2005</strong><br />
(86) 1.12.2003, PCT/IB2003/005673<br />
(21) 7913<br />
(22) 23.6.<strong>2005</strong><br />
(41) 23.6.<strong>2005</strong><br />
(51) C07D 471/04; A61K 31/437; A61P<br />
29/00; A61P 37/00; A61P 25/00<br />
(54) Pýrasóló[3,4-b]pýridín<br />
efnasambönd, og notkun þeirra sem<br />
fosfórdíesterasa hindrar.<br />
(71) Glaxo Group Limited, Glaxo<br />
Wellcome House, Berkeley Avenue,<br />
Greenford, Middlesex UB6 0NN,<br />
Bretlandi.<br />
(72) David George Allen; Diane Mary<br />
Coe; Caroline Mary Cook; Anthony<br />
William James Cooper; Michael<br />
Dennis Dowle; Christopher David<br />
Edlin; Julie Nicole Hamblin; Martin<br />
Redpath Johnson; Paul Spencer<br />
Jones; Mika Kristian Lindvall;<br />
Charlotte Jane Mitchell; Alison Judith<br />
Redgrave; Stevenage, Hertfordshire,<br />
Bretlandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 23.12.2002, GB, 0230045.7<br />
24.12.2002, GB, 0230165.3<br />
7.4.2003, GB, 0307998.5<br />
(85) 23.6.<strong>2005</strong><br />
(86) 19.12.2003, PCT/EP03/014867<br />
(21) 7914<br />
(22) 23.6.<strong>2005</strong><br />
(41) 23.6.<strong>2005</strong><br />
(51) B01D 53/12; B01J 8/18; B01J 8/24<br />
(54) Aðferð og búnaður til að fjarlægja<br />
gaskennda mengunarvalda úr<br />
útblástursgasi.<br />
(71) Outokumpu Technology Oy,<br />
Riihitontuntie 7, FIN-02200 Espoo,<br />
Finnlandi.<br />
(72) Michael Ströder, Neu-Anspach;<br />
Stuart Sneyd, Frankfurt am Main;<br />
Klaus Hasselwander, Oberursel;<br />
Þýskalandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 23.12.2002, DE, 102 60 740.0<br />
(85) 23.6.<strong>2005</strong><br />
(86) 14.11.2003, PCT/EP03/012726<br />
(21) 7915<br />
(22) 24.6.<strong>2005</strong><br />
(41) 24.6.<strong>2005</strong><br />
(51) C07D 333/20; A61K 31/381; A61P<br />
25/24<br />
(54) Ferli til að framleiða dúlóxetín og<br />
milliefni til notkunar í ferlinu.<br />
(71) Cipla Ltd., 289 Bellasis Road,<br />
Mumbai Central, Mumbai 400 008,<br />
Indlandi.<br />
(72) Dharmaraj Ramachandra Rao;<br />
Rajendra Narayanrao Kankan;<br />
Mumbai, Maharashtra, Indlandi.<br />
(74) Kjartan Ragnars, hrl., Hrauntungu<br />
66, 200 Kópavogi.<br />
(30) 19.12.2002, GB, 0229583.0<br />
(85) 24.6.<strong>2005</strong><br />
(86) 10.12.2003, PCT/GB2003/005357<br />
(21) 7916<br />
(22) 27.6.<strong>2005</strong><br />
(41) 27.6.<strong>2005</strong><br />
(51) C07C 271/10; C07C 269/06; C07C<br />
269/00; C07D 263/44; A61K 31/27;<br />
A61K 31/33<br />
(54) Arýl alkýl karbamat afleiður<br />
framleiðslu og notkun þeirra í<br />
meðferð.<br />
(71) Sanofi-Aventis, 174, avenue de<br />
France, F-75013 Paris, Frakklandi.<br />
(72) Ahmed Abouabdellah, Thiais; Antonio<br />
Almario Garcia, Chatenay Malabry;<br />
Christian Hoornaert, Antony; Antoine<br />
Ravet, Bourg la Reine; Frakklandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 23.1.2003, FR, 03/00704<br />
(85) 27.6.<strong>2005</strong><br />
(86) 22.1.2004, PCT/FR04/000139<br />
(21) 7917<br />
(22) 29.6.<strong>2005</strong><br />
(41) 29.6.<strong>2005</strong><br />
(51) A47C 3/02<br />
(54) Færanlegt tengi ætlað fyrir setbúnað.<br />
(71) Stokke AS, Håhjem, 6260 Skodje,<br />
Noregi.<br />
(72) Tor Rønnestad, Ålesund, Noregi.<br />
(74) A&P Árnason ehf., Efstaleiti 5, 103<br />
Reykjavík.<br />
(30) 20.12.2002, NO, 20026157<br />
(85) 29.6.<strong>2005</strong><br />
(86) 22.12.2003, PCT/NO2003/000438<br />
(21) 7918<br />
(22) 29.6.<strong>2005</strong><br />
(24) 21.2.2001<br />
(41) 29.6.<strong>2005</strong><br />
(51) C07D 207/27<br />
(54) 2-oxó-1-pýrrólidín afleiður, aðferð til<br />
framleiðslu á þeim og notkun þeirra.<br />
(71) UCB Farchim S.A. (AG - LDT), Z.I.<br />
Planchy, Chemin de Croix Blanche,<br />
10, C.P. 411, CH-1630 Bulle, Sviss.<br />
(72) John Surtees, Jezus-Eik Overijse,<br />
Belgíu; Violeta Marmon, Abingdon,<br />
Oxfordshire, Bretlandi; Edmond<br />
Differding, Ottignies-Louvain-la-<br />
Neuve, Belgíu; Vincent<br />
Zimmermann, Bruxelles, Belgíu.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(62) 6472<br />
(30) 23.2.2000, GB, 00 04297.8<br />
(85) 29.6.<strong>2005</strong><br />
(86) 21.2.2001, PCT/EP01/01956<br />
(21) 7919<br />
(22) 29.6.<strong>2005</strong><br />
(24) 21.2.2001<br />
(41) 29.6.<strong>2005</strong><br />
(51) C07D 207/27<br />
(54) 2-oxó-1-pýrrólidín afleiður, aðferð til<br />
framleiðslu á þeim og notkun þeirra.<br />
(71) UCB Farchim, S.A. (AG - LTD), Z.I.<br />
Planchy, Chemin de Croix Blanche,<br />
10, C.P. 411, CH-1630 Bulle, Sviss.<br />
(72) John Surtees, Jezus-Eik Overijse,<br />
Belgíu; Violeta Marmon, Abingdon,<br />
Oxfordshire, Bretlandi; Edmond<br />
Differding, Ottignies-Louvain-la-<br />
Neuve, Belgíu; Vincent<br />
Zimmermann, Bruxelles, Belgíu.